Technetium-99m ceftizoxime kit preparation

The aim of this work was to prepare a kit of 99mTc-ceftizoxime (99mTc-CFT), with stability and biological activity preserved, able to identify a septic focus (E. coli) in the experimental infection model in rats. The preparation of the CFT kit involved the use of lyophilized solutions containing the antibiotic ceftizoxime and the sodium dithionite reducing agent (6.0 mg/mL). After lyophilization, the kit was reconstituted with 1.0 mL of sodium 99mTc-pertechnetate solution (Na99mTcO4-) with an activity of 370 MBq. The solution was boiled for 10 min and filtered through a cellulose ester filter. The labeling efficiency was on the order of 92%, remaining stable for six hours and the kit remained stable for two months. The biological activity of the 99mTc-CFT was evaluated by diffusion in agar impregnated with E.coli and S. aureus. Seven Wistar rats, weighing from 200 to 250 g, were used for the development of the septic focus. After 24 hours from the induction of the infectious site (E.coli), the animals were anesthetized and 0.1 mL of 99mTc-CFT (37 MBq) was injected into the tail veins of the animals. The images were obtained with a gamma camera one, two and six hours after injection and the regions of interest (ROIs) were calculated. The diameters of the inhibition halos for 99mTc-CFT were 27.16 ± 0.23 and 27.17 ± 0.20 for S.aureus and E.coli, respectively, while those for the unlabeled CFT were 30.4 ± 0.33 and 29.43 ± 0.26, respectively. The results for the biodistribution of 99mTc-CFT in infected animals furnished a ratio of 1.97 ± 0.31, 2.10 ± 0.42 and 2.01 ± 0.42 for cpm-target/cpm-no target for the one, two and six-hour periods, respectively. The images showed a clear uptake of labeled antibiotic (99mTc-CFT) by the infectious site during the experiment. The results attest to the viability of producing a kit with 99m technetium-labeled ceftizoxime for the investigation of infectious processes.

Saved in:
Bibliographic Details
Main Authors: Diniz,Simone Odília Fernandes, Siqueira,Cristiano Ferrari, Nelson,David Lee, Martin-Comin,Josep, Cardoso,Valbert Nascimento
Format: Digital revista
Language:English
Published: Instituto de Tecnologia do Paraná - Tecpar 2005
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132005000700014
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1516-89132005000700014
record_format ojs
spelling oai:scielo:S1516-891320050007000142005-12-13Technetium-99m ceftizoxime kit preparationDiniz,Simone Odília FernandesSiqueira,Cristiano FerrariNelson,David LeeMartin-Comin,JosepCardoso,Valbert Nascimento Tc-99m Ceftizoxime infection gamma scintigraphy The aim of this work was to prepare a kit of 99mTc-ceftizoxime (99mTc-CFT), with stability and biological activity preserved, able to identify a septic focus (E. coli) in the experimental infection model in rats. The preparation of the CFT kit involved the use of lyophilized solutions containing the antibiotic ceftizoxime and the sodium dithionite reducing agent (6.0 mg/mL). After lyophilization, the kit was reconstituted with 1.0 mL of sodium 99mTc-pertechnetate solution (Na99mTcO4-) with an activity of 370 MBq. The solution was boiled for 10 min and filtered through a cellulose ester filter. The labeling efficiency was on the order of 92%, remaining stable for six hours and the kit remained stable for two months. The biological activity of the 99mTc-CFT was evaluated by diffusion in agar impregnated with E.coli and S. aureus. Seven Wistar rats, weighing from 200 to 250 g, were used for the development of the septic focus. After 24 hours from the induction of the infectious site (E.coli), the animals were anesthetized and 0.1 mL of 99mTc-CFT (37 MBq) was injected into the tail veins of the animals. The images were obtained with a gamma camera one, two and six hours after injection and the regions of interest (ROIs) were calculated. The diameters of the inhibition halos for 99mTc-CFT were 27.16 ± 0.23 and 27.17 ± 0.20 for S.aureus and E.coli, respectively, while those for the unlabeled CFT were 30.4 ± 0.33 and 29.43 ± 0.26, respectively. The results for the biodistribution of 99mTc-CFT in infected animals furnished a ratio of 1.97 ± 0.31, 2.10 ± 0.42 and 2.01 ± 0.42 for cpm-target/cpm-no target for the one, two and six-hour periods, respectively. The images showed a clear uptake of labeled antibiotic (99mTc-CFT) by the infectious site during the experiment. The results attest to the viability of producing a kit with 99m technetium-labeled ceftizoxime for the investigation of infectious processes.info:eu-repo/semantics/openAccessInstituto de Tecnologia do Paraná - TecparBrazilian Archives of Biology and Technology v.48 n.spe2 20052005-10-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132005000700014en10.1590/S1516-89132005000700014
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Diniz,Simone Odília Fernandes
Siqueira,Cristiano Ferrari
Nelson,David Lee
Martin-Comin,Josep
Cardoso,Valbert Nascimento
spellingShingle Diniz,Simone Odília Fernandes
Siqueira,Cristiano Ferrari
Nelson,David Lee
Martin-Comin,Josep
Cardoso,Valbert Nascimento
Technetium-99m ceftizoxime kit preparation
author_facet Diniz,Simone Odília Fernandes
Siqueira,Cristiano Ferrari
Nelson,David Lee
Martin-Comin,Josep
Cardoso,Valbert Nascimento
author_sort Diniz,Simone Odília Fernandes
title Technetium-99m ceftizoxime kit preparation
title_short Technetium-99m ceftizoxime kit preparation
title_full Technetium-99m ceftizoxime kit preparation
title_fullStr Technetium-99m ceftizoxime kit preparation
title_full_unstemmed Technetium-99m ceftizoxime kit preparation
title_sort technetium-99m ceftizoxime kit preparation
description The aim of this work was to prepare a kit of 99mTc-ceftizoxime (99mTc-CFT), with stability and biological activity preserved, able to identify a septic focus (E. coli) in the experimental infection model in rats. The preparation of the CFT kit involved the use of lyophilized solutions containing the antibiotic ceftizoxime and the sodium dithionite reducing agent (6.0 mg/mL). After lyophilization, the kit was reconstituted with 1.0 mL of sodium 99mTc-pertechnetate solution (Na99mTcO4-) with an activity of 370 MBq. The solution was boiled for 10 min and filtered through a cellulose ester filter. The labeling efficiency was on the order of 92%, remaining stable for six hours and the kit remained stable for two months. The biological activity of the 99mTc-CFT was evaluated by diffusion in agar impregnated with E.coli and S. aureus. Seven Wistar rats, weighing from 200 to 250 g, were used for the development of the septic focus. After 24 hours from the induction of the infectious site (E.coli), the animals were anesthetized and 0.1 mL of 99mTc-CFT (37 MBq) was injected into the tail veins of the animals. The images were obtained with a gamma camera one, two and six hours after injection and the regions of interest (ROIs) were calculated. The diameters of the inhibition halos for 99mTc-CFT were 27.16 ± 0.23 and 27.17 ± 0.20 for S.aureus and E.coli, respectively, while those for the unlabeled CFT were 30.4 ± 0.33 and 29.43 ± 0.26, respectively. The results for the biodistribution of 99mTc-CFT in infected animals furnished a ratio of 1.97 ± 0.31, 2.10 ± 0.42 and 2.01 ± 0.42 for cpm-target/cpm-no target for the one, two and six-hour periods, respectively. The images showed a clear uptake of labeled antibiotic (99mTc-CFT) by the infectious site during the experiment. The results attest to the viability of producing a kit with 99m technetium-labeled ceftizoxime for the investigation of infectious processes.
publisher Instituto de Tecnologia do Paraná - Tecpar
publishDate 2005
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132005000700014
work_keys_str_mv AT dinizsimoneodiliafernandes technetium99mceftizoximekitpreparation
AT siqueiracristianoferrari technetium99mceftizoximekitpreparation
AT nelsondavidlee technetium99mceftizoximekitpreparation
AT martincominjosep technetium99mceftizoximekitpreparation
AT cardosovalbertnascimento technetium99mceftizoximekitpreparation
_version_ 1756423723353636864